Genomic predictors for treatment of late stage prostate cancer.

about

Personalized prostate cancer care: from screening to treatment.Translation of genomics and epigenomics in prostate cancer: progress and promising directions

P2860

Q37113160-D4FB5D26-17F4-489C-BD54-E14E4AC6C54B Q42409850-99A91BBE-88BB-473D-A3D2-59BD684DB10E

P2860

Genomic predictors for treatment of late stage prostate cancer.

Item

http://www.wikidata.org/entity/Q38794112

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Genomic predictors for treatment of late stage prostate cancer.

@en

type

Item

label

Genomic predictors for treatment of late stage prostate cancer.

@en

prefLabel

Genomic predictors for treatment of late stage prostate cancer.

@en

P1476

Genomic predictors for treatment of late stage prostate cancer.

@en

P2093

Daniel H Shevrin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

The genomic complexity of primary human prostate cancer

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Integrative clinical genomics of advanced prostate cancer.

The mutational landscape of lethal castration-resistant prostate cancer

Abiraterone and increased survival in metastatic prostate cancer

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

P304

586-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.4103/1008-682X.177121

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2016-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27030083

http://www.w3.org/2001/XMLSchema#string

P921

intracellular receptor

prostate cancer

neoplasm proteins

Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase

Anzim

P932

4955183

http://www.w3.org/2001/XMLSchema#string

Genomic predictors for treatment of late stage prostate cancer.

about

P2860

P2860

Genomic predictors for treatment of late stage prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932